Clinical Trial Update: Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating a polygenic risk-driven, pragmatic statin strategy for the primary prevention of cardiovascular disease. The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Statin therapy (statin)

Snippet

Sponsor: Mikk JÜRISSON | Conditions: PRS-based Primary Prevention of CVD | Phase 4 | Status: ENROLLING_BY_INVITATION